Key Financial Data Of Group

Delta-Fly Pharma, Inc. - Filing #7583108

Concept 2022-04-01 to
2022-09-30
As at
2022-09-30
2022-07-01 to
2022-09-30
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
2021-07-01 to
2021-09-30
Key financial data of group
Business results of group
Ordinary profit (loss)
-620,957,000 JPY
-964,064,000 JPY
-555,854,000 JPY
Net assets
610,538,000 JPY
1,233,161,000 JPY
1,642,998,000 JPY
Total assets
733,575,000 JPY
1,324,352,000 JPY
1,741,139,000 JPY
Basic earnings (loss) per share
-114.88
-57.93
-178.58
-102.97
-46.22
Diluted earnings per share
Equity-to-asset ratio
0.831 xbrli:pure
0.931 xbrli:pure
0.943 xbrli:pure
Net cash provided by (used in) operating activities
-600,499,000 JPY
-940,399,000 JPY
-531,656,000 JPY
Net cash provided by (used in) investing activities
-321,000 JPY
JPY
JPY
Net cash provided by (used in) financing activities
-37,000 JPY
119,857,000 JPY
119,857,000 JPY
Cash and cash equivalents
667,706,000 JPY
1,268,492,000 JPY
1,676,103,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.